The middle ear pressure was increased by air injections and the level (pressure opening level = Pol) at which the Eustachian tube (ET) opened was determined in anaesthetized ras. At a rate of pressure increase of 0.7 kPa/s it opened at 4.1 ± 0.4 kPa. A change of the body and head position from horizontal to almost vertical increased the Pol by about 0.4 kPa (head downwards) and decreased the Pol by about 0.3 kPa (head upwards). Epinephrine tested in a dose-response experiment had no significant effect on Pol (doses from 0.01 to 10 µg/kg body weight). A surface-tension-lowering substance, Tween 20, instilled into the middle ear, reduced Pol by about 1 kPa. A change in body and head position had thus a moderate effect on the passive opening of the ET, a strong decongestant had no effect, and a surface-lowering substance, a marked effect. With increasing rates of pressure change in the middle ear, Pol increased. After instillation of Tween 20 there was an almost parallel shift to lower values of the regression line of the Pol at different rates of pressure increase.

Keywords:
Eustachian tube, Rat, Body position, Epinephrine, Surface-tension-lowering substance
This content is only available via PDF.
© 1987 S. Karger AG, Basel
1987
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.